DK0637957T3 - Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme - Google Patents

Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme

Info

Publication number
DK0637957T3
DK0637957T3 DK93909844.8T DK93909844T DK0637957T3 DK 0637957 T3 DK0637957 T3 DK 0637957T3 DK 93909844 T DK93909844 T DK 93909844T DK 0637957 T3 DK0637957 T3 DK 0637957T3
Authority
DK
Denmark
Prior art keywords
omega
oils
fatty acids
inflammatory diseases
drug
Prior art date
Application number
DK93909844.8T
Other languages
Danish (da)
English (en)
Inventor
David P Katz
Ewald Schlotzer
Peter Fuerst
Jeffrey Askanazi
Original Assignee
Fresenius Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Ag filed Critical Fresenius Ag
Application granted granted Critical
Publication of DK0637957T3 publication Critical patent/DK0637957T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
DK93909844.8T 1992-04-28 1993-04-27 Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme DK0637957T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87524392A 1992-04-28 1992-04-28

Publications (1)

Publication Number Publication Date
DK0637957T3 true DK0637957T3 (da) 1997-08-18

Family

ID=25365445

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93909844.8T DK0637957T3 (da) 1992-04-28 1993-04-27 Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme

Country Status (8)

Country Link
EP (1) EP0637957B1 (fr)
JP (1) JP3559039B2 (fr)
AT (1) ATE155684T1 (fr)
DE (1) DE59306981D1 (fr)
DK (1) DK0637957T3 (fr)
ES (1) ES2107663T3 (fr)
GR (1) GR3024526T3 (fr)
WO (1) WO1993021912A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
ES2171535T3 (es) * 1994-04-01 2002-09-16 Abbott Lab Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
EP0689835A3 (fr) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition comprenant un mélange d'acides aminés et au moins un acide gras du type N-3
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
ES2250397T3 (es) * 2000-05-05 2006-04-16 Fresenius Kabi Deutschland Gmbh Preparado de combinacion de acidos grasos omega-3 y acidos linoleicos conjugados para el tratamiento de cuadros clinicos de caracter inmunologico.
AU2002951913A0 (en) * 2002-10-08 2002-10-24 Chevis Agriservices & Consulting Pty. Limited Method of treatment
CN1166368C (zh) * 2003-02-26 2004-09-15 刘威 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036969A2 (fr) 2004-09-28 2006-04-06 Atrium Medical Corporation Formation d'une couche barriere
GB0425658D0 (en) 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
WO2008119146A2 (fr) * 2007-03-29 2008-10-09 Dair, Bicudo Piai Composition chimique en masse d'un composé pour le traitement de l'asthme bronchique et de la maladie pulmonaire obstructive chronique
WO2009047754A2 (fr) 2007-10-09 2009-04-16 Enzymotec Ltd. Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les développement et maturation intestinaux
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
WO2012009707A2 (fr) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
DE102015115877A1 (de) * 2015-09-21 2017-03-23 Eberhard Karls Universität Tübingen Medizinische Fakultät Prophylaxe und Behandlung von Mukoviszidose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung

Also Published As

Publication number Publication date
ES2107663T3 (es) 1997-12-01
JPH08500332A (ja) 1996-01-16
JP3559039B2 (ja) 2004-08-25
EP0637957A1 (fr) 1995-02-15
EP0637957B1 (fr) 1997-07-23
DE59306981D1 (de) 1997-08-28
GR3024526T3 (en) 1997-11-28
ATE155684T1 (de) 1997-08-15
WO1993021912A1 (fr) 1993-11-11

Similar Documents

Publication Publication Date Title
DK0637957T3 (da) Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme
DK0607231T3 (da) Anvendelse af en emulsion til fremstilling af et lægemiddel til intravenøs indgivelse til behandling af hudsygdomme
US5178873A (en) Essential fatty acid treatment
US5198468A (en) Essential fatty acid composition
US6624195B2 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
US5888541A (en) Fatty acid treatment
AU618814B2 (en) Essential fatty acid compositions
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
DE69328618T2 (de) Medikamente auf der Basis von Docosahexaensäure, als Plättchenaggregationshemmer und gegen cerebralen Mangel an Fettsäuren, und Verfahren zur Herstellung.
KR960010832B1 (ko) 필수지방산 합성물(Essential Fatty Acid Compositins)
NL990032I2 (nl) Vetemulsie, werkwijze voor de bereiding daarvan ende toepassing daarvan.
DK68080A (da) Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod
ATE393203T1 (de) Fettzusammensetzungen
NL980014I2 (nl) Lipiden bevattende emulsie bedoeld voor parenterale of enterale toediening.
US5516801A (en) Fatty acid treatment for ectopic calcium deposition
EP0585027B1 (fr) Utilisation d'acides gras dans le traitement de la calcification anormale des tissus
AU608571B2 (en) Composition and method for treatment of peptic ulcers
KR920021151A (ko) 면역억제특성을 갖는 약제학적 조성물을 제조하기 위한 인지질 유도체의 용도
JP7198625B2 (ja) 水性外用医薬組成物
BE901206A (fr) Emulsion pour transfusion.
RU2019139669A (ru) САМОЭМУЛЬГИРУЮЩАЯСЯ КОМПОЗИЦИЯ ω3 ЖИРНОЙ КИСЛОТЫ
JPH05148140A (ja) マラリア治療薬